As Cancer Immunotherapy Evolves, Challenges Compound for Diagnostic Development – 360Dx
|
As Cancer Immunotherapy Evolves, Challenges Compound for Diagnostic Development
360Dx NEW YORK (GenomeWeb) – At various sessions during Cambridge Healthtech Institute's Molecular Medicine Tri-Conference earlier this month, representatives from the diagnostics arena, pharmaceutical companies, and the medical oncology field discussed the … |
